07:53 AM EDT, 04/23/2024 (MT Newswires) -- ZYUS Life Sciences ( ZLSCF ) , which is developing cannabinoid-based pharmaceutical drug candidates for pain management, on Tuesday said the United States Patent and Trademark Office issued the company a patent for its lead drug candidate, Trichomylin softgel capsules.

This is the seventh patent in this patent family, joining other jurisdictions such as Canada, Australia, Israel, India, Korea and South Africa.